InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

Holista Colltech Limited (ASX: HCT) - Announcements

- Current share price for HCT : $0.067

ASX company news and announcements for Holista Colltech Limited (HCT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Holista Colltech Limited (HCT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Holista Colltech Limited (HCT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Holista Colltech Limited (HCT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Quarterly Activity and Cashflow Report 30 Jul 2026 8:29AM $0.080 $0.067 fallen by 16.25%
$25 Final Payment Made in Settlement of ProImmune Litigation 17 Jul 2026 8:38AM $0.080 $0.067 fallen by 16.25%
$25 Proposed issue of securities - HCT 9 Jul 2026 11:04AM $0.080 $0.067 fallen by 16.25%
$25 Convertible Loan to Fund Settlement of ProImmune Matter 9 Jul 2026 10:26AM $0.080 $0.067 fallen by 16.25%
$25 Acquisition of Industrial Land in Collie 19 Jun 2026 8:21AM $0.067 $0.067 fallen by 0%
$25 Clarification - Binding JV for Collie Collagen Facility 17 Jun 2026 4:28PM $0.071 $0.067 fallen by 5.63%
$25 Results of Meeting 25 May 2026 5:19PM $0.070 $0.067 fallen by 4.29%
$25 Annual General Meeting Presentation 25 May 2026 5:04PM $0.070 $0.067 fallen by 4.29%
$25 Holista Executes Binding JV for Collie Collagen Facility 5 May 2026 8:16AM $0.062 $0.067 risen by 8.06%
$25 Quarterly Activity and Cashflow Report 28 Apr 2026 4:55PM $0.065 $0.067 risen by 3.08%
$25 Annual General Meeting - Notice of Access 24 Apr 2026 4:17PM $0.051 $0.067 risen by 31.37%
$25 Notice of Annual General Meeting/Proxy Form 24 Apr 2026 4:14PM $0.051 $0.067 risen by 31.37%
$25 Reinstatement to Quotation 22 Apr 2026 2:55PM $0.063 $0.067 risen by 6.35%
$25 ProImmune Judgement and Settlement 22 Apr 2026 2:55PM $0.063 $0.067 risen by 6.35%
$25 Continuation of Suspension 14 Apr 2026 9:59AM $0.063 $0.067 risen by 6.35%
$25 Suspension from Quotation 10 Apr 2026 9:09AM $0.063 $0.067 risen by 6.35%
$25 Trading Halt 8 Apr 2026 9:22AM $0.063 $0.067 risen by 6.35%
$25 Appendix 4G 30 Mar 2026 8:18AM $0.063 $0.067 risen by 6.35%
$25 Annual Report to shareholders 30 Mar 2026 8:17AM $0.063 $0.067 risen by 6.35%
$25 Appendix 4E - Preliminary Final Report 27 Feb 2026 9:14AM $0.073 $0.067 fallen by 8.22%
$25 Quarterly Activity and Cashflow Report 30 Jan 2026 9:15AM $0.084 $0.067 fallen by 20.24%
$25 Update on ASIC Proceedings - Costs Notice Received 11 Dec 2025 8:20AM $0.090 $0.067 fallen by 25.56%
$25 Becoming a substantial holder 13 Nov 2025 11:57AM $0.090 $0.067 fallen by 25.56%
$25 Cleansing Notice 12 Nov 2025 8:25AM $0.090 $0.067 fallen by 25.56%
$25 Notification of cessation of securities - HCT 12 Nov 2025 8:25AM $0.090 $0.067 fallen by 25.56%

1 - 25 of 523 results

Page 1 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.